Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
europe blog main
3
×
fda
3
×
life sciences
national
3
×
national blog main
national top stories
new york blog main
boston blog main
boston top stories
clinical trials
europe top stories
new york top stories
san francisco blog main
san francisco top stories
abbvie
accent therapeutics
acute myeloid leukemia
aducanumab
allergan
alx oncology
alzheimer's disease
amblyotech
amgen
asklepios biopharmaceutical
autoimmune diseases
berkeley lights
bioeurope
biogen
biohaven
biomarin pharmaceutical
biotech ipos
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cancer drugs
cancer immunotherapy
cara therapeutics
What
new
3
×
fda
ipo
medicines
activity
adults
allergan
approvals
approved
arrival
bio
biogen
biotech
clamped
class
companies
covid
days
delays
developing
economic
fast
hasn’t
including
industry
ipos
isn’t
life
lot
market
migraine
momentum
monday
nod
oric’s
pill
raised
research
roundup
science
Language
unset
Current search:
fda
×
biotech
×
" europe blog main "
×
new
×
national
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines